Medical University Innsbruck
Innsbruck, Tyrol, 6020, Austria
Location status: Recruiting
Location contact
Fabian Barbieri, MD
CONTACT
Wolfgang Dichtl, MD PhD
CONTACT
NCT Number: NCT02448485
TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.
Interested in participating?
Request InfoAll sexes
Observational
Innsbruck, Tyrol, 6020, Austria
Location status: Recruiting
Fabian Barbieri, MD
CONTACT
Wolfgang Dichtl, MD PhD
CONTACT
Development of symptoms such as heart failure, syncope or angina pectoris is the well-established indication for valve operation in patients with severe aortic stenosis. However, many patients tend to misinterpretate or even ignore symptom onset, and irreversible myocardial dysfunction may occur. Measurement of aortic valve area by transthoracic echocardiography using the continuity equation is prone to methological mistakes, whereas transvalvular gradients are usually easy to quantify but may underestimate hemodynamic effects in the presence of low flow (stroke volume index below 35 ml/m2). All these shortcomings in clinical routine may be overcome by objectively and easily assessable parameters indicating advanced aortic stenosis. Severe aortic valve calcification is such a risk factor for worse prognosis. However, assessment of valve calcification by echocardiography is a subjective measurement and highly operator-dependent. Quantification of valve calcification by multi detector computed tomography is limited by exposure to radiation, availibilty and cost.
A laboratory parameter already used in clinical routine would fullfill the requirements for such a risk stratification much better. Natriuretic peptides may be of interest in this context, but their plasma levels are strongly influenced by age, sex, concomitant arterial hypertension and/or renal dysfunction and volume status. Recently, high-sensitivity troponin plasma levels have been suggested to indicate ongoing myocardial fibrosis in aortic stenosis. A small study with 60 patients suggested that hs-TnT predicte the operative outcome of AS. We therefore set out to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical or interventional aortic valve implantation
Time frame: up to 8 years
Contact information is provided by the study sponsor or research team.
Fabian Barbieri
CONTACT
Wolfgang Dichtl, MD, PhD
CONTACT
Medical University Innsbruck
Other
High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis
Acronym: TASS-2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07420907
Aortic Stenosis, Aortic Stenosis Disease
Chicago, Illinois, United States
View Trial DetailsNCT03268135
Aortic Stenosis, Aortic Valve Disease
San Donato Milanese, Milan, Italy
View Trial DetailsNCT02856620
Aortic Stenosis, Aortic Valve Disease
Montreal, Quebec, Canada
View Trial DetailsNCT02628509
Aortic Stenosis, Aortic Valve Disease
Lille, France
View Trial Details